Dell’s right triangle top is just pitch-perfect. It has been bleeding out several days now.

Slope initially began as a blog, so this is where most of the website’s content resides. Here we have tens of thousands of posts dating back over a decade. These are listed in reverse chronological order. Click on any category icon below to see posts tagged with that particular subject, or click on a word in the category cloud on the right side of the screen for more specific choices.
Eli Lilly has traditionally scared me. I mean, let’s face it, a totally evil company that sells drugs at 10,000 the times of the cost of materials which has the pathetic U.S. healthcare system over a barrel is a pretty damned good business model. It is sporting a P/E in the triple digits, which is normally what you would associate with a new biotech company at the cusp of curing cancer, not an ancient organization that sells stupidly named pills to the desperate.

One of the hottest stocks in history until a few months ago was Celsius Holdings (CELH), which made some kind of drink with God knows what kinds of chemicals in it. Anyway, it has lost 66% of its value rather quickly. Easy come, easy go, right, bucky?

There is one chart I’ve looked at repeatedly but could never bring myself to short since it is relatively thinly traded: Huntsman (HUN):

Here’s a chart (GTLS) I’ve suggested many times, always with the proviso that it’s so thinly traded that it’s tough to get into it. So – – – another ship that’s sailing away (but has plenty of downside still).
